Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together
Biotech

BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed

BMS formed a broad partnership with Hengrui, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines.
Nick Paul Taylor May 12, 2026 1:56am
cash money

Alphabet's AI biotech Isomorphic Labs bags $2.1B series B

May 12, 2026 11:45am
syneos-herov2-04302026png

MRD as a Decision Engine: Rethinking Oncology Trial Design

Brought to you by Syneos Health
Palm tree branches bending as storm clouds approach

AstraZeneca’s $800M bet undermined by immunogenicity in phase 3

May 12, 2026 9:28am
Sketch of lungs

Enterprise posts CF win, succeeding where Big Pharma stumbled

May 12, 2026 4:00am
Warren Biddle

Kyverna begins rolling FDA submission for autoimmune CAR-T in SPS

May 12, 2026 4:27pm
More News
Fierce Pharma

FDA's embattled Marty Makary steps down as commissioner

May 12, 2026 2:30pm

Fierce Biotech Fundraising Tracker '26: Isomorphic & more

May 12, 2026 10:00am

Boehringer makes €407M bet on Immunitas’ inflammatory asset

May 12, 2026 9:57am

Bayer scraps ph.1-stage hypertension, neuropathic pain drugs

May 12, 2026 5:07am